The Discounted Cash Flow (DCF) valuation of Henan Lingrui Pharmaceutical Co Ltd (600285.SS) is 24.73 CNY. With the latest stock price at 23.43 CNY, the upside of Henan Lingrui Pharmaceutical Co Ltd based on DCF is 5.5%.
Based on the latest price of 23.43 CNY and our DCF valuation, Henan Lingrui Pharmaceutical Co Ltd (600285.SS) is a buy. buying 600285.SS stocks now will result in a potential gain of 5.5%.
| Range | Selected | |
| WACC / Discount Rate | 9.0% - 11.3% | 10.2% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 19.96 - 33.60 | 24.73 |
| Upside | -14.8% - 43.4% | 5.5% |